ATE210976T1 - Arzneimittel bestehend aus diclofenac - Google Patents

Arzneimittel bestehend aus diclofenac

Info

Publication number
ATE210976T1
ATE210976T1 AT97927045T AT97927045T ATE210976T1 AT E210976 T1 ATE210976 T1 AT E210976T1 AT 97927045 T AT97927045 T AT 97927045T AT 97927045 T AT97927045 T AT 97927045T AT E210976 T1 ATE210976 T1 AT E210976T1
Authority
AT
Austria
Prior art keywords
diclofenac
medicinal product
product consisting
medicinal
product
Prior art date
Application number
AT97927045T
Other languages
English (en)
Inventor
Alberto Reiner
Giorgio Reiner
Original Assignee
Applied Pharma Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Pharma Res filed Critical Applied Pharma Res
Application granted granted Critical
Publication of ATE210976T1 publication Critical patent/ATE210976T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT97927045T 1996-05-17 1997-05-15 Arzneimittel bestehend aus diclofenac ATE210976T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000992A IT1283029B1 (it) 1996-05-17 1996-05-17 Composizioni farmaceutiche a base di diclofenac
PCT/EP1997/002709 WO1997044023A1 (en) 1996-05-17 1997-05-15 Pharmaceutical compositions based on diclofenac

Publications (1)

Publication Number Publication Date
ATE210976T1 true ATE210976T1 (de) 2002-01-15

Family

ID=11374276

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01119117T ATE229801T1 (de) 1996-05-17 1997-05-15 Arzneimittel bestehend aus diclofenac
AT97927045T ATE210976T1 (de) 1996-05-17 1997-05-15 Arzneimittel bestehend aus diclofenac

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01119117T ATE229801T1 (de) 1996-05-17 1997-05-15 Arzneimittel bestehend aus diclofenac

Country Status (24)

Country Link
EP (2) EP0906092B1 (de)
KR (1) KR100441179B1 (de)
AR (1) AR007165A1 (de)
AT (2) ATE229801T1 (de)
AU (1) AU733083B2 (de)
CA (1) CA2254144C (de)
DE (2) DE69718077T2 (de)
DK (2) DK0906092T3 (de)
EE (1) EE9800400A (de)
ES (2) ES2187489T3 (de)
HK (1) HK1043939B (de)
HR (1) HRP970269A2 (de)
IT (1) IT1283029B1 (de)
LT (1) LT4530B (de)
LV (1) LV12250B (de)
MA (1) MA24183A1 (de)
NZ (1) NZ332655A (de)
PL (1) PL188883B1 (de)
PT (2) PT1159960E (de)
SK (1) SK157698A3 (de)
TW (1) TW505525B (de)
WO (1) WO1997044023A1 (de)
YU (1) YU19797A (de)
ZA (1) ZA974270B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687542B2 (en) 1996-05-17 2010-03-30 Kowa Pharmaeuticals America, Inc. Rapidly bioavailable tablet and capsule formulations of diclofenac
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
CA2566384C (en) 2004-05-28 2010-08-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US7700125B2 (en) 2006-02-07 2010-04-20 Kowa Pharmaceuticals America, Inc. Moisture resistant container systems for rapidly bioavailable dosage forms
US7939561B2 (en) 2006-02-07 2011-05-10 Apr Applied Pharma Research S.A. Blister packaging for acute pain regimens
EP2480212B1 (de) * 2009-09-25 2016-07-06 Novartis Consumer Health S.A. Orale pharmazeutische Zusammensetzung mit Diclofenac
US11957792B2 (en) 2012-04-19 2024-04-16 Glatt Ag Taste-masked pharmaceutical compositions containing diclofenac
MX2017015699A (es) * 2015-06-05 2018-12-11 Lupin Ltd Composiciones de acido diclofenaco.
IT201700009711A1 (it) * 2017-01-30 2018-07-30 Applied Pharma Res Sodium free Diclofenac potassium oral solutions Soluzioni orali di Diclofenac potassico prive di sodio
US11260026B2 (en) 2018-12-14 2022-03-01 Apr Applied Pharma Research Sa Ready to use diclofenac stick packs
EP4164612A1 (de) 2020-06-10 2023-04-19 Apr Applied Pharma Research S.A. Bioverfügbare diclofenac-formulierungen auf zuckerbasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3607339A1 (de) * 1986-03-06 1987-09-10 Merck Patent Gmbh Pharmazeutische zubereitung
EP0466650A2 (de) * 1990-07-11 1992-01-15 Warner-Lambert Company Entzündungshemmende Behandlung mit nichtsteroiden Mitteln
DE4120311A1 (de) * 1991-06-20 1992-12-24 Kali Chemie Pharma Gmbh Konservierte pharmazeutische zubereitungen
EP0867426B1 (de) * 1993-09-07 2002-06-26 Gerhard Dr. Gergely Modifizierte Kristalle einer festen, essbaren, organischen Säure
JPH10500982A (ja) * 1994-05-27 1998-01-27 ファーマーク、ネダーランド、ベスローテン、フェンノートシャップ 医薬組成物
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs

Also Published As

Publication number Publication date
ITMI960992A1 (it) 1997-11-17
HRP970269A2 (en) 1998-04-30
EP0906092B1 (de) 2001-12-19
LV12250B (en) 1999-09-20
NZ332655A (en) 2000-04-28
CA2254144A1 (en) 1997-11-27
AR007165A1 (es) 1999-10-13
PL188883B1 (pl) 2005-05-31
MA24183A1 (fr) 1997-12-31
WO1997044023A1 (en) 1997-11-27
HK1043939B (zh) 2003-05-16
LT98160A (en) 1999-03-25
SK157698A3 (en) 2000-11-07
EE9800400A (et) 1999-06-15
DK1159960T3 (da) 2003-03-31
AU3167697A (en) 1997-12-09
ATE229801T1 (de) 2003-01-15
ES2170396T3 (es) 2002-08-01
KR20000010792A (ko) 2000-02-25
ZA974270B (en) 1998-01-30
PT906092E (pt) 2002-06-28
DE69709349T2 (de) 2002-07-25
LV12250A (lv) 1999-04-20
EP0906092A1 (de) 1999-04-07
LT4530B (lt) 1999-07-26
YU19797A (sh) 1999-07-28
DE69718077D1 (de) 2003-01-30
PT1159960E (pt) 2003-03-31
PL329919A1 (en) 1999-04-26
ES2187489T3 (es) 2003-06-16
ITMI960992A0 (de) 1996-05-17
DK0906092T3 (da) 2002-04-15
DE69709349D1 (de) 2002-01-31
KR100441179B1 (ko) 2004-11-26
DE69718077T2 (de) 2003-09-11
AU733083B2 (en) 2001-05-03
TW505525B (en) 2002-10-11
EP1159960B1 (de) 2002-12-18
CA2254144C (en) 2007-11-20
HK1043939A1 (en) 2002-10-04
EP1159960A1 (de) 2001-12-05
IT1283029B1 (it) 1998-04-03

Similar Documents

Publication Publication Date Title
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
ATE187063T1 (de) Arzneimittel
FI954402A (fi) Uusi farmaseuttinen tuote
ATE138566T1 (de) Tramadol enthaltendes arzneimittel mit verzögerter wirkstoffabgabe
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
SG70562A1 (en) Potentiation of drug response
DE69900162D1 (de) Arzneimittel enthaltend Oxaliplatin
DE69530325D1 (de) Aerosol-arzneiformulierungen
NO962606D0 (no) Farmasöytisk sammensetning
NO973612D0 (no) Nytt farmasöytisk preparat
DE69737936D1 (de) Arzneimittel
ATE237320T1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
ATE210976T1 (de) Arzneimittel bestehend aus diclofenac
NO973610D0 (no) Nytt farmasöytisk preparat
ITMI941169A0 (it) Formulazioni farmaceutiche
FI973280A0 (fi) Farmaseuttinen koostumus
NO973611D0 (no) Nytt farmasöytisk preparat
BR9711981A (pt) Produto farmac-utico cristalino
NO950950D0 (no) Farmasöytisk preparat
BR9606066A (pt) Composto e formulação farmacêutica
BR9605777A (pt) Composição farmacêutica
DE69819203D1 (de) Trinkbares arzneimittel
NO964309D0 (no) Farmasöytisk sammensetning
ZA948357B (en) Potentiation of drug response

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0906092

Country of ref document: EP